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Infections are one of the major causes of mortality in the
first year after organ transplantation (1). Bacterial infection
is the most frequent type of infection. Chang et al. found
that 82% of fever episodes in the first two years after liver
transplantation were nosocomial infections; bacterial infec-
tions were found in 62% of cases (2).
Approximately half of bacterial infections occur within two
weeks after liver transplantation. The following risk factors
related to these infections were identified: 1. Immunosup-
pression; 2. Recipient characteristics; 3. Procedural character-
istics; and 4. Donor characteristics. Organ transplant donors
are exposedto several situations that are associated with a risk
of infection; therefore, donors have the potential to transmit
microorganisms to organ transplantation recipients (1).
Transmission through the graft is well described for some
infections,such astoxoplasmosis in hearttransplantationand
mycobacteriosis in liver, kidney and lung transplantation
(3,4). Virus transmission is also well documented. Donors are
typically screened for the following viruses: human immu-
nodeficiency virus (HIV), hepatitis B and C viruses, EBV,
CMV and human T-cell lymphotropic virus (HTLV). The
transmission of HTLV in this manner has not been
documented but is highly probable (5).
Bacteria and fungi can be transferred to the allograft by
contamination during the recovery, preservation or hand-
ling of the organ or at the time of transplantation.
Contamination from a donor infection is most likely the
most critical because a large inoculum of microorganisms
can be transmitted. Information regarding nosocomial
infection (fungal and bacterial) retrieved from donor organs,
however, is limited. The donor-to-host transmission of
bacterial infection has been documented in some case
reports and large series. In Canada, one donor transmitted
methicillin-resistant Staphylococcus aureus (S. aureus) to two
kidney recipients and one cornea recipient (6). Organ
contamination by Pseudomonas aeruginosa, S. aureus and
Candida species at the time of harvesting has been reported
in kidney transplantation. The agents were isolated from
donor fluids and graft preservation fluid, and the recipients
developed serious infections (7).
Several studies have reported a low risk of recipient
infection when the donor had bacteremia and both donor
and recipient were treated. Four studies analyzed the
outcome of solid organ transplantation when there was
documented bacteremia in the donor (7-10). Lumbreras et
al. identified bacteremias in 5% of liver and heart donors
(10). The most common agent was S. aureus. The majority of
recipients received treatment for agents isolated in the
donor blood cultures; there was no negative impact on the
survival of the graft or of the patient. Freeman et al.
analyzed the outcome of 212 patients who received organs
from 95 donors with bacteremia (11). Surprisingly, none of
the recipients developed infections caused by the agents
found in the donors.
The organs of donors with bacterial meningitis can be
transplanted without increasing the risk of infection in
recipients. Lopez-Navidad et al. (12) reported on 16 re-
cipients who received organs from donors diagnosed with
meningitis. All of the recipients were treated post-operatively
for the same microorganism as isolated from the donors, and
no patient developed an infection. In another series, 33 liver
transplantsfromdonorswith meningitisweredescribed;there
were no cases of transmission to a recipient. In this study, both
donors and recipients had been treated for the isolated agents
(13). These data suggest that it is safeto transplant organs from
donors with bacterial infection if the donors do not have signs
of sepsis, the causative agent of the infection is identified, and
the recipients receive the appropriate treatment immediately
post-transplantation. However, infections that are not cor-
rectly identified may be transmitted. Hypothetically, the risk is
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289higher for microorganisms resistant to the prophylaxis regi-
men routinely used in transplant care units.
Approximately 5% of donors have positive blood cultures
at the time of transplantation, but some studies report this
figure to be as high as 20% (11,14). The international
consensus is that systematic blood culturing should be
performed for all transplanted organs. There is no current
recommendation in Brazil.
Considering the risks for bacterial infection and the
potential benefits of knowing the microbiological status of
the donor organ, we propose that systematic cultures of
donor materials should be performed. Blood cultures
should be performed for all organ transplantations and
bronchoalveolar fluid culture should be performed in all
cases of lung transplantation (Figure 1).
Theprimarygoalofstandardizationistoprovideimportant
infectious and microbiological information (Figure 1), which
could be helpful in determining the appropriate prophylactic
and therapeutic measures for use in transplant recipients.
APPENDIX
AVALIAC ¸A ˜ O DE INFECC ¸O ˜ ES BACTERIANAS EM
DOADORES DE O ´ RGA ˜ OS
As infecc ¸o ˜es constituem-se em uma das principais causas
de morbi-mortalidade no primeiro ano apo ´s o transplante
de o ´rga ˜os (1), sendo mais frequentes as infecc ¸o ˜es bacteri-
anas. Chang et al. demonstraram que 82% dos episo ´dios de
febre em dois anos de seguimento apo ´s transplante de
fı ´gado sa ˜o de origem hospitalar, e desses 62% sa ˜o de origem
bacteriana (2).
Cerca de metade das infecc ¸o ˜es bacterianas ocorre em ate ´
duas semanas apo ´s o transplante. Alguns fatores de risco
foram identificados como determinantes na incide ˆncia dessas
infecc ¸o ˜es: 1. Fatores relacionados a ` imunossupressa ˜o; 2.
Fatores relacionados ao receptor; 3. Fatores relacionados ao
procedimento, e 4. Fatores relacionados ao doador. Devido a `s
condic ¸o ˜es clı ´nicas dos doadores, estes esta ˜o submetidos a
va ´rios fatores de risco para infecc ¸o ˜es nosocomiais, com
potencial de transmissa ˜o para o receptor (1).
Algumas infecc ¸o ˜es ja ´ foram bem definidas como passı ´veis
de serem adquiridas do enxerto, como toxoplasmose em
transplantados de corac ¸a ˜o e mico bacteriose em transplanta-
dos de rim, fı ´gado e pulma ˜o (3,4). A transmissa ˜o de infecc ¸o ˜es
por vı ´rus tambe ´me ´ bem documentada. Pesquisam-se os
seguintes vı ´rus, rotineiramente, no doador: vı ´rus da imuno-
deficie ˆncia humana (HIV), vı ´rus das hepatites B e C, EBV,
CMV e vı ´rus humano linfotro ´pico de ce ´lulas T (HTLV), este
u ´ltimo sem transmissa ˜o documentada, pore ´m altamente
prova ´vel (5).
Poucas informac ¸o ˜es existem, entretanto, sobre a possibili-
dade de transmissa ˜o de agentes de infecc ¸a ˜o hospitalar
(bacte ´rias e fungos) atrave ´s do enxerto. No Canada ´, foi
descrita a transmissa ˜o de Staphylococcus aureus (S. aureus)
resistente a oxacilina de um doador para dois receptores de
rim e um de co ´rnea (6). Descreveu-se, em transplante de rim,
contaminac ¸a ˜o do enxerto durante a retirada e preservac ¸a ˜o
do o ´rga ˜o. Os agentes identificados foram Pseudomonas
Figure 1 - Evaluation of Bacterial Infection in Organ Donors.
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ou da soluc ¸a ˜o de preservac ¸a ˜o, e responsa ´veis por graves
infecc ¸o ˜es nos receptores (7).
Alguns estudos mostram que as bacteremias no doador,
quando identificadas e tratadas, tanto no receptor quanto no
doador, na ˜o representam risco de infecc ¸a ˜o para o receptor.
Quatro estudos avaliam a evoluc ¸a ˜o de transplantados que
receberam o ´rga ˜os de doadores com bacteremia documen-
tada (7-10). Lumbreras et al. identificaram 5% de bacter-
emias em doadores de fı ´gado e corac ¸a ˜o (10). O principal
agente identificado foi S. aureus. A maioria dos receptores
recebeu tratamento para o microorganismo identificado na
hemocultura do doador. Na ˜o houve diminuic ¸a ˜o na sobre-
vida do enxerto ou do paciente. Freeman et al. avaliaram a
evoluc ¸a ˜o de 212 pacientes que receberam o ´rga ˜os de 95
doadores com bacteremia (11). A maioria recebeu antibio-
ticoprofilaxia ativa contra essas bacte ´rias, e nenhum
receptor evoluiu com infecc ¸a ˜o pelo mesmo agente do
doador.
Doadores com meningite bacteriana tambe ´m foram
utilizados sem que isto acarretasse em maior risco de sepse
nos receptores. Lopez-Navidad et al. descreveram 16
transplantados que receberam o ´rga ˜os de doadores com
meningite bacteriana (12). Todos receberam tratamento no
po ´s-operato ´rio para os agentes isolados no doador, e
nenhum paciente evoluiu com infecc ¸a ˜o por esses agentes.
Outra se ´rie de 33 transplantes de fı ´gado com doadores com
meningite foi descrita sem nenhum caso de infecc ¸a ˜o nos
receptores; neste estudo tanto os doadores quanto os
receptores receberam tratamento para o agente isolado (13).
Esses dados sugerem que, aparentemente, e ´ seguro
receber o ´rga ˜os de doadores com infecc ¸a ˜o bacteriana que
na ˜o apresentem sepse clı ´nica, desde que essas infecc ¸o ˜es
tenham agente etiolo ´gico identificado no doador e sejam
tratadas adequadamente no po ´s-operato ´rio imediato.
Pore ´m, infecc ¸o ˜es que na ˜o foram diagnosticadas adequada-
mente podem ser transmitidas. Teoricamente este risco e ´
maior para microorganismos na ˜o sensı ´veis aos antibio ´ticos
comumente usados na profilaxia do transplante.
Em me ´dia, 5% dos doadores apresentam hemocultura
positiva no momento do transplante, pore ´m em algumas
se ´ries a positividade das hemoculturas chega a 23% (11,14).
Alguns consensos internacionais recomendam a coleta de
hemocultura de todos os doadores de o ´rga ˜os. No Brasil na ˜o
ha ´ recomendac ¸a ˜o especı ´fica.
Considerando os riscos da aquisic ¸a ˜od ei n f e c c ¸a ˜o bacteriana
e o potencial benefı ´cio de se obter dados microbiolo ´gicos dos
doadores de o ´rga ˜os, propomos uma sistematizac ¸a ˜od ec o l e t a
de culturas destes doadores (Figure 1). Sugere-se incluir
basicamente a coleta de hemoculturas, exceto para os casos de
transplante de pulma ˜o, em que a identificac ¸a ˜od ec o l o n i z a c ¸a ˜o
de vias ae ´reas tambe ´m tem utilidade demonstrada. O objetivo
prima ´rio desta padronizac ¸a ˜oe ´ proporcionar informac ¸a ˜o
microbiolo ´gica einfecciosa(Figure1)importante para auxiliar
na adoc ¸a ˜o de medidas profila ´ticas e terape ˆuticas no paciente
transplantado.
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